查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1754164

静脉注射（IV）布洛芬市场报告，按产品剂量（100 毫克剂量、200 毫克剂量、400 毫克剂量、800 毫克剂量）、适应症（疼痛/发炎、发烧）、年龄组（儿科、成人）和地区划分，2025 年至 2033 年

Intravenous (IV) Ibuprofen Market Report by Product Dose (100 Mg Dose, 200 Mg Dose, 400 Mg Dose, 800 Mg Dose), Indication (Pain/Inflammatory, Fever), Age Group (Pediatrics, Adults), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球静脉注射 (IV) 布洛芬市场规模达 73 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 132 亿美元，2025-2033 年期间的成长率 (CAGR) 为 6.45%。

布洛芬属于非类固醇类抗发炎药 (NSAID)，用于治疗发炎、疼痛和发烧。它抑制合成前列腺素 (PG) 所需的环氧合酶 COZ-1 和 COX-2。静脉注射 (IV) 布洛芬可单独使用或与其他药物合併使用，以缓解轻度至重度不适。它直接注射到静脉中，以阻止人体产生某些导致发炎的天然物质。它有助于减少麻醉性镇痛药的需求，降低疼痛程度，且安全性极佳。静脉注射布洛芬也有助于改善疼痛控制，并减少骨科、腹部手术和发烧患者中阿片类药物的使用。

静脉注射（IV）布洛芬市场趋势：

全球老年人口的稳定增长以及关节炎、心血管疾病 (CVD) 和癌症发病率的上升，为市场带来了积极的前景。同时，用于管理和治疗发炎性疾病、类风湿性疾病、轻度至中度疼痛、发烧、经痛和骨关节炎的产品的广泛采用，也有利于市场的成长。此外，繁忙的工作日程和不健康的生活方式，以及随之而来的体能活动和营养不良，导致慢性病发病率上升，这也是另一个促进成长的因素。此外，用于治疗轻度发烧、牙痛、胃肠道疼痛和儿科动脉导管的产品使用率的增加，也为市场的成长提供了动力。此外，静脉注射布洛芬也用于缓解肌肉或风湿痛、背痛、神经痛、扭伤、拉伤、运动伤害以及肌肉骨骼疾病，这促进了市场的成长。此外，膝关节或髋关节置换术后骨科患者对静脉注射布洛芬的需求不断增长，以减轻疼痛并减少吗啡的使用，这也对市场成长产生了积极的影响。其他因素，包括医疗基础设施的显着改善、个人健康意识的增强以及消费者支出能力的提升，预计将推动市场成长。

本报告回答的关键问题

  • 2024年全球静脉注射（IV）布洛芬市场规模？ 2025-2033年全球静脉注射（IV）布洛芬市场的预期成长率是多少？
  • 推动全球静脉注射（IV）布洛芬市场发展的关键因素有哪些？
  • COVID-19 对全球静脉注射（IV）布洛芬市场有何影响？
  • 根据适应症，全球静脉注射（IV）布洛芬市场如何分布？
  • 根据年龄组，全球静脉注射（IV）布洛芬市场是如何分布的？
  • 全球静脉注射（IV）布洛芬市场的主要区域有哪些？
  • 全球静脉注射（IV）布洛芬市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球静脉注射（IV）布洛芬市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品剂量

  • 100毫克剂量
  • 200毫克剂量
  • 400毫克剂量
  • 800毫克剂量

第七章：市场区隔：依指标

  • 疼痛/炎症
  • 发烧

第八章：市场区隔：依年龄段

  • 儿科
  • 成年人

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Cumberland Pharmaceuticals Inc.
    • Hyloris Pharmaceuticals SA
    • Recordati Rare Diseases Inc.
    • VALMOR Laboratories CA
    • Xgen Pharmaceuticals Djb Inc.
Product Code: SR112025A6440

The global intravenous (IV) ibuprofen market size reached USD 7.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.45% during 2025-2033.

Ibuprofen belongs to the nonsteroidal anti-inflammatory drug (NSAID) class used to treat inflammation, pain, and fever. It inhibits cyclooxygenase COZ-1 and COX-2 enzymes that are required for the synthesis of prostaglandins (PG). Intravenous (IV) ibuprofen is used alone or with other medicines to relieve mild to severe discomfort. It is injected directly into the vein to block the body's production of certain natural substances that cause inflammation. It helps to reduce narcotic analgesic requirements and lower pain levels with an excellent safety profile. IV ibuprofen also aids in improving pain control and reducing the usage of opioid drugs in orthopedic and abdominal surgeries and fever.

Intravenous (IV) Ibuprofen Market Trends:

The steadily rising geriatric population and the increasing prevalence of arthritis, cardiovascular diseases (CVDs), and cancer across the globe are creating a positive outlook for the market. In line with this, the widespread product adoption to manage and treat inflammatory diseases, rheumatoid disorders, mild to moderate pain, fever, dysmenorrhea, and osteoarthritis is favoring the market growth. Moreover, hectic working schedules and unhealthy lifestyles, along with a consequent decline in physical activity and proper nutrition, have led to a rise in the incidences of chronic diseases, which is acting as another growth-inducing factor. Apart from this, the increasing product utilization to treat mild fever, dental pain, gastrointestinal pain, and ductus arteriosus in pediatrics is providing an impetus to the market growth. Moreover, IV ibuprofen is employed to relieve muscle or rheumatic pain, backache, neuralgia, sprains, strains, sports injuries, and musculoskeletal diseases, which is facilitating the market growth. Furthermore, the increasing demand for IV ibuprofen in orthopedic patients post knee or hip replacement surgeries to reduce pain and morphine use is positively influencing the market growth. Other factors, including significant improvements in the healthcare infrastructure, growing health consciousness among individuals, and the rising expenditure capacities of consumers, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Product Dose:

  • 100 Mg Dose
  • 200 Mg Dose
  • 400 Mg Dose
  • 800 Mg Dose

Breakup by Indication:

  • Pain/Inflammatory
  • Fever

Breakup by Age Group:

  • Pediatrics
  • Adults

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Cumberland Pharmaceuticals Inc., Hyloris Pharmaceuticals SA, Recordati Rare Diseases Inc., VALMOR Laboratories CA and Xgen Pharmaceuticals Djb Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global Intravenous (IV) ibuprofen market in 2024?
  • 2.What is the expected growth rate of the global Intravenous (IV) ibuprofen market during 2025-2033?
  • 3.What are the key factors driving the global Intravenous (IV) ibuprofen market?
  • 4.What has been the impact of COVID-19 on the global Intravenous (IV) ibuprofen market?
  • 5.What is the breakup of the global Intravenous (IV) ibuprofen market based on the indication?
  • 6.What is the breakup of the global Intravenous (IV) ibuprofen market based on the age group?
  • 7.What are the key regions in the global Intravenous (IV) ibuprofen market?
  • 8.Who are the key players/companies in the global Intravenous (IV) ibuprofen market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Intravenous (IV) Ibuprofen Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Dose

  • 6.1 100 Mg Dose
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 200 Mg Dose
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 400 Mg Dose
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 800 Mg Dose
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Pain/Inflammatory
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fever
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age Group

  • 8.1 Pediatrics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Adults
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Cumberland Pharmaceuticals Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hyloris Pharmaceuticals SA
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Recordati Rare Diseases Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 VALMOR Laboratories CA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Xgen Pharmaceuticals Djb Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio

List of Figures

  • Figure 1: Global: Intravenous Ibuprofen Market: Major Drivers and Challenges
  • Figure 2: Global: Intravenous Ibuprofen Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Intravenous Ibuprofen Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Intravenous Ibuprofen Market: Breakup by Product Dose (in %), 2024
  • Figure 5: Global: Intravenous Ibuprofen Market: Breakup by Indication (in %), 2024
  • Figure 6: Global: Intravenous Ibuprofen Market: Breakup by Age Group (in %), 2024
  • Figure 7: Global: Intravenous Ibuprofen Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Intravenous Ibuprofen (100 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Intravenous Ibuprofen (100 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Intravenous Ibuprofen (200 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Intravenous Ibuprofen (200 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Intravenous Ibuprofen (400 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Intravenous Ibuprofen (400 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Intravenous Ibuprofen (800 Mg Dose) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Intravenous Ibuprofen (800 Mg Dose) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Intravenous Ibuprofen (Pain/Inflammatory) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Intravenous Ibuprofen (Fever) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Intravenous Ibuprofen (Fever) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Intravenous Ibuprofen (Pediatrics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Intravenous Ibuprofen (Pediatrics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Intravenous Ibuprofen (Adults) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Intravenous Ibuprofen (Adults) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: North America: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: North America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: United States: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: United States: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Canada: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Canada: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Asia-Pacific: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: China: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: China: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Japan: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Japan: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: India: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: India: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: South Korea: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: South Korea: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Australia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Australia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Indonesia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Indonesia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Europe: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Europe: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Germany: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Germany: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: France: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: France: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: United Kingdom: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: United Kingdom: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Italy: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Italy: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Spain: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Spain: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Russia: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Russia: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Latin America: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Latin America: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Brazil: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Brazil: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Mexico: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Mexico: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Middle East and Africa: Intravenous Ibuprofen Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Middle East and Africa: Intravenous Ibuprofen Market: Breakup by Country (in %), 2024
  • Figure 72: Middle East and Africa: Intravenous Ibuprofen Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Global: Intravenous Ibuprofen Industry: SWOT Analysis
  • Figure 74: Global: Intravenous Ibuprofen Industry: Value Chain Analysis
  • Figure 75: Global: Intravenous Ibuprofen Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Intravenous Ibuprofen Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Intravenous Ibuprofen Market Forecast: Breakup by Product Dose (in Million USD), 2025-2033
  • Table 3: Global: Intravenous Ibuprofen Market Forecast: Breakup by Indication (in Million USD), 2025-2033
  • Table 4: Global: Intravenous Ibuprofen Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
  • Table 5: Global: Intravenous Ibuprofen Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Intravenous Ibuprofen Market: Competitive Structure
  • Table 7: Global: Intravenous Ibuprofen Market: Key Players